Low-dose ofatumumab for multidrug-resistant nephrotic syndrome in children: a randomized placebo-controlled trial

References

Page 1

	Year	Citations
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial Kazumoto Iijima, Mayumi Sako, Kandai Nozu, The Lancet Steroid-dependent Nephrotic SyndromeChronic Kidney DiseaseChildhood ArthritisRenal PathologyPediatrics	2014	428
Short-Term Effects of Rituximab in Children with Steroid- and Calcineurin-Dependent Nephrotic Syndrome Pietro Ravani, Alberto Magnasco, Alberto Edefonti, Clinical Journal of the American Society of Nephrology	2011	212
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome Pietro Ravani, Roberta Rossi, Alice Bonanni, Journal of the American Society of Nephrology GlomerulonephritisRheumatologyUrologyRituximab GroupMedicine	2015	197
Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome Alberto Magnasco, Pietro Ravani, Alberto Edefonti, Journal of the American Society of Nephrology GlomerulonephritisStandard TreatmentsRenal FunctionBaseline ProteinuriaMedicine	2012	171
Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome Biswanath Basu, Anja Sander, Birendranath Roy, JAMA Pediatrics	2018	146
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor–dependent idiopathic nephrotic syndrome Pietro Ravani, Alessandro Ponticelli, Chiara Siciliano, Kidney International UrologyMedicineRenal PathologyPharmacologyEffective Long-term Treatment	2013	127
Ofatumumab for the treatment of childhood nephrotic syndrome Chia-shi Wang, Rochelle Liverman, Rouba Garro, Pediatric Nephrology GlomerulonephritisLupus NephritisChronic Kidney DiseasePediatricsChildhood Nephrotic Syndrome	2017	73
Use of Rituximab in Focal Glomerulosclerosis Relapses After Renal Transplantation Luca Dello Strologo, Isabella Guzzo, Chiara Laurenzi, Transplantation	2009	61
Adverse events linked with the use of chimeric and humanized anti‐CD20 antibodies in children with idiopathic nephrotic syndrome Alice Bonanni, Marta Calatroni, Matteo D’Alessandro, British Journal of Clinical Pharmacology	2018	54
Low-dose ofatumumab for rituximab-resistant nephrotic syndrome Alice Bonanni, Roberta Rossi, Corrado Murtas, BMJ Case Reports Glomerular DiseaseGlomerulonephritisUrologyRenal FunctionLupus Nephritis	2015	48

Page 1